Mounjaro® vs. Ozempic®: What's the Difference?

DON’T JUST TAKE OUR WORD FOR IT True Stories Of Transformation My clinician is amazing

With an impressive career spanning over 15 years in the medical field, Amparo has not only established herself as a highly skilled and board-certified Family Medicine Nurse Practitioner but also as a compassionate advocate for patient well-being

This remarkable compound has been a subject of extensive research for its potent regenerative properties

Tirzepatide, a dual GIP/GLP-1 receptor agonist, showed even more robust results in the SURPASS trials, with participants losing up to 22.5% of body weight

For peptides like ipamorelin and CJC-1295, the most valuable thing a clinician can learn is how to reason about them honestly : how to read the strength and limits of the evidence, how to interpret regulatory status, how to evaluate sourcing, and how to communicate uncertainty to patients without overpromising

doi: 10.1530/EJE-16-0467 29 VaduvaPBonnetFBertheratJ

Timely follow-up is crucial in weight loss marketing

doi: 10.1016/j.tripleo.2008.02.001 20 KhoddamiMSquireJZielenskaMThornerP

Overall, adults ages 50 to 64 were most likely to have used GLP-1 drugs, but younger adults were more likely to use them solely for weight loss, according to the KFF survey

Tirzepatide activates two gut hormone pathways, GLP-1 and GIP, while semaglutide activates only GLP-1

In a flash

Cushing syndrome results from excess cortisol secretion